304 related articles for article (PubMed ID: 17919697)
1. Efficacy of transcutaneous electrical nerve stimulation in children with overactive bladder refractory to pharmacotherapy.
Malm-Buatsi E; Nepple KG; Boyt MA; Austin JC; Cooper CS
Urology; 2007 Nov; 70(5):980-3. PubMed ID: 17919697
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of transcutaneous parasacral electrical stimulation for overactive bladder in children: long-term results.
Lordêlo P; Soares PV; Maciel I; Macedo A; Barroso U
J Urol; 2009 Dec; 182(6):2900-4. PubMed ID: 19846164
[TBL] [Abstract][Full Text] [Related]
3. Transcutaneous electrical nerve stimulation for refractory daytime urinary urge incontinence.
Hagstroem S; Mahler B; Madsen B; Djurhuus JC; Rittig S
J Urol; 2009 Oct; 182(4 Suppl):2072-8. PubMed ID: 19695629
[TBL] [Abstract][Full Text] [Related]
4. Frequency of wetting is predictive of response to anticholinergic treatment in children with overactive bladder.
Van Arendonk KJ; Austin JC; Boyt MA; Cooper CS
Urology; 2006 May; 67(5):1049-53; discussion 1053-4. PubMed ID: 16698366
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of transcutaneous electrical neural stimulation therapy in patients with urinary incontinence resistant to initial medical treatment or biofeedback.
Tugtepe H; Thomas DT; Ergun R; Kalyoncu A; Kaynak A; Kastarli C; Dagli TE
J Pediatr Urol; 2015 Jun; 11(3):137.e1-5. PubMed ID: 25824876
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial.
Peters KM; Macdiarmid SA; Wooldridge LS; Leong FC; Shobeiri SA; Rovner ES; Siegel SW; Tate SB; Jarnagin BK; Rosenblatt PL; Feagins BA
J Urol; 2009 Sep; 182(3):1055-61. PubMed ID: 19616802
[TBL] [Abstract][Full Text] [Related]
7. Posterior tibial nerve stimulation vs parasacral transcutaneous neuromodulation for overactive bladder in children.
Barroso U; Viterbo W; Bittencourt J; Farias T; Lordêlo P
J Urol; 2013 Aug; 190(2):673-7. PubMed ID: 23422257
[TBL] [Abstract][Full Text] [Related]
8. Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed?
Yucel S; Akkaya E; Guntekin E; Kukul E; Danisman A; Akman S; Baykara M
Urology; 2005 Feb; 65(2):369-73. PubMed ID: 15708055
[TBL] [Abstract][Full Text] [Related]
9. [Tibial nerve transcutaneous stimulation for refractory idiopathic overactive bladder in children and adolescents].
Bouali O; Even L; Mouttalib S; Moscovici J; Galinier P; Game X
Prog Urol; 2015 Sep; 25(11):665-72. PubMed ID: 26022237
[TBL] [Abstract][Full Text] [Related]
10. Double anticholinergic therapy for refractory overactive bladder.
Bolduc S; Moore K; Lebel S; Lamontagne P; Hamel M
J Urol; 2009 Oct; 182(4 Suppl):2033-8. PubMed ID: 19695628
[TBL] [Abstract][Full Text] [Related]
11. Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults.
Rai BP; Cody JD; Alhasso A; Stewart L
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD003193. PubMed ID: 23235594
[TBL] [Abstract][Full Text] [Related]
12. Effect of pelvic floor interferential electrostimulation on urodynamic parameters and incontinency of children with myelomeningocele and detrusor overactivity.
Kajbafzadeh AM; Sharifi-Rad L; Baradaran N; Nejat F
Urology; 2009 Aug; 74(2):324-9. PubMed ID: 19476983
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous tibial nerve neuromodulation is well tolerated in children and effective for treating refractory vesical dysfunction.
De Gennaro M; Capitanucci ML; Mastracci P; Silveri M; Gatti C; Mosiello G
J Urol; 2004 May; 171(5):1911-3. PubMed ID: 15076308
[TBL] [Abstract][Full Text] [Related]
14. Initial trial of timed voiding is warranted for all children with daytime incontinence.
Allen HA; Austin JC; Boyt MA; Hawtrey CE; Cooper CS
Urology; 2007 May; 69(5):962-5. PubMed ID: 17482943
[TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy of percutaneous tibial nerve stimulation for different types of lower urinary tract dysfunction in children.
Capitanucci ML; Camanni D; Demelas F; Mosiello G; Zaccara A; De Gennaro M
J Urol; 2009 Oct; 182(4 Suppl):2056-61. PubMed ID: 19695611
[TBL] [Abstract][Full Text] [Related]
16. Treatment with propiverine in children suffering from nonneurogenic overactive bladder and urinary incontinence: results of a randomized placebo-controlled phase 3 clinical trial.
Marschall-Kehrel D; Feustel C; Persson de Geeter C; Stehr M; Radmayr C; Sillén U; Strugala G
Eur Urol; 2009 Mar; 55(3):729-36. PubMed ID: 18502028
[TBL] [Abstract][Full Text] [Related]
17. Effects of transcutaneous neuromodulation (TENS) on overactive bladder symptoms in children: a randomized controlled trial.
Sillén U; Arwidsson C; Doroszkiewicz M; Antonsson H; Jansson I; Stålklint M; Abrahamsson K; Sjöström S
J Pediatr Urol; 2014 Dec; 10(6):1100-5. PubMed ID: 24881806
[TBL] [Abstract][Full Text] [Related]
18. Sacral nerve stimulation for refractory overactive bladder in the elderly population.
White WM; Mobley JD; Doggweiler R; Dobmeyer-Dittrich C; Klein FA
J Urol; 2009 Oct; 182(4):1449-52. PubMed ID: 19683295
[TBL] [Abstract][Full Text] [Related]
19. Solifenacin for therapy resistant overactive bladder.
Hoebeke P; De Pooter J; De Caestecker K; Raes A; Dehoorne J; Van Laecke E; Vande Walle J
J Urol; 2009 Oct; 182(4 Suppl):2040-4. PubMed ID: 19695608
[TBL] [Abstract][Full Text] [Related]
20. Bladder training versus combination of propiverine with bladder training for female urinary frequency. A prospective, randomized, comparative study.
Kim SW; Song SH; Ku JH
Gynecol Obstet Invest; 2008; 65(2):123-7. PubMed ID: 17917464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
